Rachel Pauls, MD
Urogynecology and Reconstructive Pelvic Surgery · West Chester, OHNPI 1326121534
Payments from drug & device makers
What this record shows
Medtronic accounts for 91.2% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,357, more than ten times the $18 reported in 2019. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in OH, where the typical reported total is $3,689.
Across 30 payments — averaging $62.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$42
- GSK$30
- Boston Scientific$28
- Coloplast$24
- Astellas Pharma US Inc$23
- plus $17 from 1 others
What the payments were for
- Travel & lodging$1,03756%
- Food & beverage$82744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $1,702 |
| AbbVie | 2 | $42 |
| GSK | 2 | $30 |
| Boston Scientific | 1 | $28 |
| Coloplast | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Axonics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,865 in reported general payments places this provider in the 25th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.
See all urogynecology and reconstructive pelvic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 229 | $147,091 |
| GemtesaVibegron | 88 | $58,996 |
| Solifenacin Succinate | 369 | $15,702 |
| Estradiol | 269 | $15,472 |
| Trospium Chloride ErTrospium Chloride | 50 | $8,520 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 107 | $7,908 |
| Mirabegron ErMirabegron | 13 | $7,872 |
| Fosfomycin Tromethamine | 15 | $4,163 |
| Trospium Chloride | 71 | $3,070 |
| Methenamine Hippurate | 48 | $2,700 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 126 | $2,395 |
| Tolterodine Tartrate ErTolterodine Tartrate | 28 | $1,870 |
| Trimethoprim | 38 | $1,735 |
| Solu-CortefHydrocortisone Sodium Succ/Pf | 12 | $1,448 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 12 | $370 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $23 | $147,091229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.
Other urogynecology and reconstructive pelvic surgery in West Chester
- Mickey KarramWest Chester$127K
- Hayley BarnesWest Chester$3K
- Robert OwensWest Chester$2K
- Costas ApostolisStrongsville$982K
- Sangeeta MahajanMayfield Hts$48K
- Emily SlopnickCleveland$37K
- Mitesh ParekhZanesville$33K
- Andrew CroakMaumee$26K
- Ly Hoang RobertsCleveland$23K
- Marie ParaisoCleveland$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.